Erik T. Engelson serves as Executive at Lucira Health, Inc., where they oversee executive responsibilities. Since joining the company, Erik T. Engelson has executed 7 insider transactions totaling $798.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 3, 2023 involved selling 60,000 shares valued at $65.4K.
Erik T. Engelson currently holds 23,282 shares of Lucira Health, Inc. (LHDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erik T. Engelson has been a net seller of LHDX stock. They have purchased $141.3K and sold $657.3K worth of shares.
Erik T. Engelson's most recent insider trade was on Mar 3, 2023, when they sold 60,000 shares at $1.09 per share.
Get notified when new Form 4 filings are submitted
| $0.82 |
| Discretionary |
| Mar 3, 2023 | LHDX | $591.9K | Sale | 574,666 | $1.03 | Discretionary |
| Sep 15, 2022 | LHDX | $36.4K | Purchase | 20,000 | $1.82 | Discretionary |
| Jun 16, 2022 | LHDX | $14.9K | Purchase | 10,000 | $1.49 | Discretionary |
| Mar 15, 2022 | LHDX | $90.0K | Purchase | 30,000 | $3.00 | Discretionary |
| Feb 9, 2021 | LHDX | $0 | Conversion | 23,282 | $N/A | Discretionary |